Stocktoria
Qiagen N.V. QIA.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Qiagen N.V. financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $2.1B | $2.0B | $2.0B | $2.1B |
| Gross profit | $1.3B | $967.4M | $1.2B | $1.4B |
| R&D expense | $187.5M | $193.5M | $198.5M | $189.9M |
| SG&A expense | $583.7M | $564.4M | $579.2M | $603.9M |
| Operating income | $520.3M | $199.9M | $445.2M | $576.2M |
| Interest expense | $33.3M | $43.8M | $53.4M | $58.4M |
| Income tax | $65.4M | $37.6M | $88.5M | $89.4M |
| Net income | $424.9M | $83.6M | $341.3M | $423.2M |
| EPS (diluted) | $2.04 | $0.40 | $1.65 | $2.79 |
| Operating cash flow | $654.3M | $673.6M | $459.5M | $715.3M |
| Free cash flow | $447.2M | $502.3M | $296.7M | $565.9M |
| Cash & equivalents | $839.0M | $663.6M | $668.1M | $730.7M |
| Inventory | $301.9M | $279.3M | $398.4M | $358.0M |
| Total assets | $6.3B | $5.7B | $6.1B | $6.3B |
| Total liabilities | $2.5B | $2.1B | $2.3B | $2.8B |
| Shareholders' equity | $3.8B | $3.6B | $3.8B | $3.5B |
Growth · year-over-year · Revenue CAGR -0.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +5.7% | +0.7% | -8.2% | — |
| Net income growth | +408.3% | -75.5% | -19.4% | — |
| EPS growth | +409.8% | -75.7% | -40.8% | — |
| Free cash flow growth | -11.0% | +69.3% | -47.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.